Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma
Author(s) -
Sanjay De Mel,
Yunxin Chen,
Adeline Lin,
Teck Guan Soh,
Melissa Ooi,
Eng Soo Yap,
Lara Kristina Sioco Donato,
Nurul Aidah Abdul Halim,
Joanna Mah,
Karen Lim,
Li Mei Poon,
Belinda Tan,
Yelly,
Hui Li Lim,
Liang Piu Koh,
Bee Choo Tai,
Zhaojin Chen,
Wee Joo Chng,
Satish Kumar Gopalakrishnan,
Lip Kun Tan
Publication year - 2018
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2018.04.001
Subject(s) - cyclophosphamide , multiple myeloma , vinorelbine , peripheral blood , mobilization , medicine , peripheral , peripheral blood stem cells , chemotherapy , hematopoietic stem cell transplantation , transplantation , political science , cisplatin , law
High dose Cyclophosphamide (Cy) and Vinorelbine Cyclophosphamide (Vino-Cy) are stem cell (SC) mobilisation options for patients with multiple myeloma (MM). We present a comparison of mobilisation outcomes using these regimens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom